Enhancement of histone deacetylase inhibitor's efficacy with hydroxychloroquine via autophagy inhibition in pediatric tumor cell lines

被引:0
|
作者
Cruz, Abigail Joy [1 ]
Bansal, Hima [1 ]
Tomlinson, Gail [1 ]
Bansal, Sanjay [1 ]
Weitman, Steven [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
关键词
D O I
10.1158/1538-7445.PEDCA15-B36
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B36
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Combined proteasome and histone deacetylase inhibition in breast cancer cell lines.
    Rosche, M.
    Zavrski, I.
    Schmid, P.
    Kaiser, M.
    Elsmer, E.
    Possinger, K.
    Sezer, O.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S71 - S71
  • [22] Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats
    Anwen Shao
    Zhen Wang
    Haijian Wu
    Xiao Dong
    Yong Li
    Sheng Tu
    Junjia Tang
    Mingfei Zhao
    Jianmin Zhang
    Yuan Hong
    Molecular Neurobiology, 2016, 53 : 18 - 27
  • [23] Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats
    Shao, Anwen
    Wang, Zhen
    Wu, Haijian
    Dong, Xiao
    Li, Yong
    Tu, Sheng
    Tang, Junjia
    Zhao, Mingfei
    Zhang, Jianmin
    Hong, Yuan
    MOLECULAR NEUROBIOLOGY, 2016, 53 (01) : 18 - 27
  • [24] The histone deacetylase inhibitor LAQ824 is selectively toxic to tumor cell lines including multidrug resistant cells
    Atadja, P
    Remiszewski, L
    Trogani, N
    Walker, H
    Hsu, M
    Gao, L
    Yeleswarapu, L
    Perez, L
    Cohen, P
    Lassota, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S103 - S103
  • [25] HISTONE DEACETYLASE INHIBITOR PCI-24781 SHOWS INHIBITION OF CELL PROLIFERATION AND CLONOGENIC SURVIVAL IN PEDIATRIC GLIOBLASTOMA CELLS
    Andrade, P. V.
    Andrade, A. F.
    de Paula Queiroz, R. G.
    Scrideli, C. A.
    Tone, L. G.
    Valera, E. T.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S277 - S277
  • [26] Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines
    Enzenhofer, Elisabeth
    Kadletz, Lorenz
    Stanisz, Isabella
    Kotowski, Ulana
    Seemann, Rudolf
    Schmid, Rainer
    Thurnher, Dietmar
    Heiduschka, Gregor
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (05): : 900 - 907
  • [27] Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines
    Han, Xiaohong
    Zhang, Ningning
    Yao, Jiarui
    Shi, Yuankai
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S484 - S484
  • [28] Histone deacetylase inhibitor, PCI-24781, induces growth inhibition and apoptosis in hematopoietic tumor-derived cell lines and primary leukemia cells.
    Buggy, Joseph
    Balasubramanian, Sriram
    Ramos, Jason
    Sirisawad, Mint
    Naumovski, Louie
    BLOOD, 2006, 108 (11) : 177B - 177B
  • [29] Molecular Sequelae of Histone Deacetylase Inhibition in Human Retinoblastoma Cell Lines: Clinical Implications
    Poulaki, Vassiliki
    Mitsiades, Constantine S.
    Kotoula, Vassiliki
    Negri, Joseph
    McMullan, Ciaran
    Miller, Joan W.
    Marks, Paul A.
    Mitsiades, Nicholas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (09) : 4072 - 4079
  • [30] Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
    Di Fazio, Pietro
    Waldegger, Petra
    Jabari, Samir
    Lingelbach, Susanne
    Montalbano, Roberta
    Ocker, Matthias
    Slater, Emily P.
    Bartsch, Detlef K.
    Illig, Romana
    Neureiter, Daniel
    Wissniowski, Thaddeus T.
    ONCOTARGET, 2016, 7 (20) : 28998 - 29010